Nevro to pay Boston Scientific $20 million in patent infringement case

Nevro Corp. is expected to pay $20 million to Boston Scientific Corp. after a Delaware jury found that the medical device company had infringed on two Boston Scientific patents related to the manufacturing of a spinal cord stimulation technology, the company said late Monday.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.